Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LabLogic Group Holdings is a private UK-based life science tools and scientific instrumentation company focused on the detection and measurement of radioactivity for life sciences, PET/nuclear medicine, and radiation safety applications. Through LabLogic Systems and affiliated group companies, it develops and manufactures radiochromatography instruments, gamma counting and spectroscopy systems, radiopharmaceutical quality control software, and related workflow tools used in regulated environments. Its products are used by pharmaceutical companies, PET manufacturers, hospitals, universities, and radiation safety organizations, with installations in more than 100 countries. The group also includes businesses such as Southern Scientific, Knight Imaging, and Care Wise, extending its reach into radiation detection equipment, medical furniture, and gamma probe systems. Rather than a therapeutic drug developer, LabLogic is best understood as a commercial healthcare and life science technology supplier serving radiopharmacy, nuclear medicine, and research markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LabLogic Group Holdings.